Global Repurposed Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4759534
- 100 Pages
- January 2022
- Pharmaceuticals
The United States Repurposed Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Repurposed Drugs market, reaching US$ million by the year 2028. As for the Europe Repurposed Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Repurposed Drugs players cover Teva, Novartis, Mylan, and Johnson & Johnson, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Repurposed Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Generic Drugs
Clinical Trial Failed Drugs
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cardiovascular Diseases
Mental Illness
Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Repurposed Drugs Market Size 2017-2028
2.1.2 Repurposed Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Repurposed Drugs Segment by Type
2.2.1 Generic Drugs
2.2.2 Clinical Trial Failed Drugs
2.3 Repurposed Drugs Market Size by Type
2.3.1 Repurposed Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Repurposed Drugs Market Size Market Share by Type (2017-2022)
2.4 Repurposed Drugs Segment by Application
2.4.1 Cardiovascular Diseases
2.4.2 Mental Illness
2.4.3 Cancer
2.4.4 Other
2.5 Repurposed Drugs Market Size by Application
2.5.1 Repurposed Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Repurposed Drugs Market Size Market Share by Application (2017-2022)
3 Repurposed Drugs Market Size by Player
3.1 Repurposed Drugs Market Size Market Share by Players
3.1.1 Global Repurposed Drugs Revenue by Players (2020-2022)
3.1.2 Global Repurposed Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Repurposed Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Repurposed Drugs by Regions
4.1 Repurposed Drugs Market Size by Regions (2017-2022)
4.2 Americas Repurposed Drugs Market Size Growth (2017-2022)
4.3 APAC Repurposed Drugs Market Size Growth (2017-2022)
4.4 Europe Repurposed Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Repurposed Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Repurposed Drugs Market Size by Country (2017-2022)
5.2 Americas Repurposed Drugs Market Size by Type (2017-2022)
5.3 Americas Repurposed Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Repurposed Drugs Market Size by Region (2017-2022)
6.2 APAC Repurposed Drugs Market Size by Type (2017-2022)
6.3 APAC Repurposed Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Repurposed Drugs by Country (2017-2022)
7.2 Europe Repurposed Drugs Market Size by Type (2017-2022)
7.3 Europe Repurposed Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Repurposed Drugs by Region (2017-2022)
8.2 Middle East & Africa Repurposed Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Repurposed Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Repurposed Drugs Market Forecast
10.1 Global Repurposed Drugs Forecast by Regions (2023-2028)
10.1.1 Global Repurposed Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Repurposed Drugs Forecast
10.1.3 APAC Repurposed Drugs Forecast
10.1.4 Europe Repurposed Drugs Forecast
10.1.5 Middle East & Africa Repurposed Drugs Forecast
10.2 Americas Repurposed Drugs Forecast by Country (2023-2028)
10.2.1 United States Repurposed Drugs Market Forecast
10.2.2 Canada Repurposed Drugs Market Forecast
10.2.3 Mexico Repurposed Drugs Market Forecast
10.2.4 Brazil Repurposed Drugs Market Forecast
10.3 APAC Repurposed Drugs Forecast by Region (2023-2028)
10.3.1 China Repurposed Drugs Market Forecast
10.3.2 Japan Repurposed Drugs Market Forecast
10.3.3 Korea Repurposed Drugs Market Forecast
10.3.4 Southeast Asia Repurposed Drugs Market Forecast
10.3.5 India Repurposed Drugs Market Forecast
10.3.6 Australia Repurposed Drugs Market Forecast
10.4 Europe Repurposed Drugs Forecast by Country (2023-2028)
10.4.1 Germany Repurposed Drugs Market Forecast
10.4.2 France Repurposed Drugs Market Forecast
10.4.3 UK Repurposed Drugs Market Forecast
10.4.4 Italy Repurposed Drugs Market Forecast
10.4.5 Russia Repurposed Drugs Market Forecast
10.5 Middle East & Africa Repurposed Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Repurposed Drugs Market Forecast
10.5.2 South Africa Repurposed Drugs Market Forecast
10.5.3 Israel Repurposed Drugs Market Forecast
10.5.4 Turkey Repurposed Drugs Market Forecast
10.5.5 GCC Countries Repurposed Drugs Market Forecast
10.6 Global Repurposed Drugs Forecast by Type (2023-2028)
10.7 Global Repurposed Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Teva
11.1.1 Teva Company Information
11.1.2 Teva Repurposed Drugs Product Offered
11.1.3 Teva Repurposed Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Teva Main Business Overview
11.1.5 Teva Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Repurposed Drugs Product Offered
11.2.3 Novartis Repurposed Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Mylan
11.3.1 Mylan Company Information
11.3.2 Mylan Repurposed Drugs Product Offered
11.3.3 Mylan Repurposed Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Mylan Main Business Overview
11.3.5 Mylan Latest Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Information
11.4.2 Johnson & Johnson Repurposed Drugs Product Offered
11.4.3 Johnson & Johnson Repurposed Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Johnson & Johnson Main Business Overview
11.4.5 Johnson & Johnson Latest Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Repurposed Drugs Product Offered
11.5.3 Pfizer Repurposed Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Pfizer Main Business Overview
11.5.5 Pfizer Latest Developments
11.6 Bausch Health
11.6.1 Bausch Health Company Information
11.6.2 Bausch Health Repurposed Drugs Product Offered
11.6.3 Bausch Health Repurposed Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bausch Health Main Business Overview
11.6.5 Bausch Health Latest Developments
11.7 GSK
11.7.1 GSK Company Information
11.7.2 GSK Repurposed Drugs Product Offered
11.7.3 GSK Repurposed Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 GSK Main Business Overview
11.7.5 GSK Latest Developments
11.8 ChemRar Group
11.8.1 ChemRar Group Company Information
11.8.2 ChemRar Group Repurposed Drugs Product Offered
11.8.3 ChemRar Group Repurposed Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 ChemRar Group Main Business Overview
11.8.5 ChemRar Group Latest Developments
11.9 Glenmark
11.9.1 Glenmark Company Information
11.9.2 Glenmark Repurposed Drugs Product Offered
11.9.3 Glenmark Repurposed Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Glenmark Main Business Overview
11.9.5 Glenmark Latest Developments
11.10 Fujifilm
11.10.1 Fujifilm Company Information
11.10.2 Fujifilm Repurposed Drugs Product Offered
11.10.3 Fujifilm Repurposed Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Fujifilm Main Business Overview
11.10.5 Fujifilm Latest Developments
11.11 Dr. Reddy
11.11.1 Dr. Reddy Company Information
11.11.2 Dr. Reddy Repurposed Drugs Product Offered
11.11.3 Dr. Reddy Repurposed Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Dr. Reddy Main Business Overview
11.11.5 Dr. Reddy Latest Developments
11.12 R-Pharma
11.12.1 R-Pharma Company Information
11.12.2 R-Pharma Repurposed Drugs Product Offered
11.12.3 R-Pharma Repurposed Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 R-Pharma Main Business Overview
11.12.5 R-Pharma Latest Developments
12 Research Findings and Conclusion
Table 1. Repurposed Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Generic Drugs
Table 3. Major Players of Clinical Trial Failed Drugs
Table 4. Repurposed Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Repurposed Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Repurposed Drugs Market Size Market Share by Type (2017-2022)
Table 7. Repurposed Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Repurposed Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Repurposed Drugs Market Size Market Share by Application (2017-2022)
Table 10. Global Repurposed Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Repurposed Drugs Revenue Market Share by Player (2020-2022)
Table 12. Repurposed Drugs Key Players Head office and Products Offered
Table 13. Repurposed Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Repurposed Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Repurposed Drugs Market Size Market Share by Regions (2017-2022)
Table 18. Americas Repurposed Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Repurposed Drugs Market Size Market Share by Country (2017-2022)
Table 20. Americas Repurposed Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Repurposed Drugs Market Size Market Share by Type (2017-2022)
Table 22. Americas Repurposed Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Repurposed Drugs Market Size Market Share by Application (2017-2022)
Table 24. APAC Repurposed Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Repurposed Drugs Market Size Market Share by Region (2017-2022)
Table 26. APAC Repurposed Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Repurposed Drugs Market Size Market Share by Type (2017-2022)
Table 28. APAC Repurposed Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Repurposed Drugs Market Size Market Share by Application (2017-2022)
Table 30. Europe Repurposed Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Repurposed Drugs Market Size Market Share by Country (2017-2022)
Table 32. Europe Repurposed Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Repurposed Drugs Market Size Market Share by Type (2017-2022)
Table 34. Europe Repurposed Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Repurposed Drugs Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Repurposed Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Repurposed Drugs Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Repurposed Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Repurposed Drugs Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Repurposed Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Repurposed Drugs Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Repurposed Drugs
Table 43. Key Market Challenges & Risks of Repurposed Drugs
Table 44. Key Industry Trends of Repurposed Drugs
Table 45. Global Repurposed Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Repurposed Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Repurposed Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Repurposed Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Repurposed Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Repurposed Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 51. Teva Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 52. Teva Repurposed Drugs Product Offered
Table 53. Teva Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Teva Main Business
Table 55. Teva Latest Developments
Table 56. Novartis Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 57. Novartis Repurposed Drugs Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Novartis Latest Developments
Table 61. Mylan Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 62. Mylan Repurposed Drugs Product Offered
Table 63. Mylan Main Business
Table 64. Mylan Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Mylan Latest Developments
Table 66. Johnson & Johnson Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 67. Johnson & Johnson Repurposed Drugs Product Offered
Table 68. Johnson & Johnson Main Business
Table 69. Johnson & Johnson Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Johnson & Johnson Latest Developments
Table 71. Pfizer Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 72. Pfizer Repurposed Drugs Product Offered
Table 73. Pfizer Main Business
Table 74. Pfizer Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Pfizer Latest Developments
Table 76. Bausch Health Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 77. Bausch Health Repurposed Drugs Product Offered
Table 78. Bausch Health Main Business
Table 79. Bausch Health Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Bausch Health Latest Developments
Table 81. GSK Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 82. GSK Repurposed Drugs Product Offered
Table 83. GSK Main Business
Table 84. GSK Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. GSK Latest Developments
Table 86. ChemRar Group Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 87. ChemRar Group Repurposed Drugs Product Offered
Table 88. ChemRar Group Main Business
Table 89. ChemRar Group Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. ChemRar Group Latest Developments
Table 91. Glenmark Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 92. Glenmark Repurposed Drugs Product Offered
Table 93. Glenmark Main Business
Table 94. Glenmark Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Glenmark Latest Developments
Table 96. Fujifilm Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 97. Fujifilm Repurposed Drugs Product Offered
Table 98. Fujifilm Main Business
Table 99. Fujifilm Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Fujifilm Latest Developments
Table 101. Dr. Reddy Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 102. Dr. Reddy Repurposed Drugs Product Offered
Table 103. Dr. Reddy Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Dr. Reddy Main Business
Table 105. Dr. Reddy Latest Developments
Table 106. R-Pharma Details, Company Type, Repurposed Drugs Area Served and Its Competitors
Table 107. R-Pharma Repurposed Drugs Product Offered
Table 108. R-Pharma Main Business
Table 109. R-Pharma Repurposed Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. R-Pharma Latest Developments
List of Figures
Figure 1. Repurposed Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Repurposed Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Repurposed Drugs Market Size Market Share by Type in 2021
Figure 7. Repurposed Drugs in Cardiovascular Diseases
Figure 8. Global Repurposed Drugs Market: Cardiovascular Diseases (2017-2022) & ($ Millions)
Figure 9. Repurposed Drugs in Mental Illness
Figure 10. Global Repurposed Drugs Market: Mental Illness (2017-2022) & ($ Millions)
Figure 11. Repurposed Drugs in Cancer
Figure 12. Global Repurposed Drugs Market: Cancer (2017-2022) & ($ Millions)
Figure 13. Repurposed Drugs in Other
Figure 14. Global Repurposed Drugs Market: Other (2017-2022) & ($ Millions)
Figure 15. Global Repurposed Drugs Market Size Market Share by Application in 2021
Figure 16. Global Repurposed Drugs Revenue Market Share by Player in 2021
Figure 17. Global Repurposed Drugs Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Repurposed Drugs Market Size 2017-2022 ($ Millions)
Figure 19. APAC Repurposed Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Europe Repurposed Drugs Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Repurposed Drugs Market Size 2017-2022 ($ Millions)
Figure 22. Americas Repurposed Drugs Value Market Share by Country in 2021
Figure 23. Americas Repurposed Drugs Consumption Market Share by Type in 2021
Figure 24. Americas Repurposed Drugs Market Size Market Share by Application in 2021
Figure 25. United States Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Repurposed Drugs Market Size Market Share by Region in 2021
Figure 30. APAC Repurposed Drugs Market Size Market Share by Application in 2021
Figure 31. China Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Repurposed Drugs Market Size Market Share by Country in 2021
Figure 38. Europe Repurposed Drugs Market Size Market Share by Type in 2021
Figure 39. Europe Repurposed Drugs Market Size Market Share by Application in 2021
Figure 40. Germany Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Repurposed Drugs Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Repurposed Drugs Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Repurposed Drugs Market Size Market Share by Application in 2021
Figure 48. Egypt Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Repurposed Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 54. APAC Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 55. Europe Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 57. United States Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Canada Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 61. China Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Japan Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 63. Korea Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 65. India Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 66. Australia Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 67. Germany Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 68. France Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 69. UK Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Italy Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Russia Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 72. Spain Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 75. Israel Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Repurposed Drugs Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Repurposed Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
